Document is current
Any future updates will be listed below
-
Authors
Hjelmeland, Marta E.
Lien, Hilde E.
Berg, Hege F.
Woie, Kathrine
Werner, Henrica M. J.
Amant, Frédéric
Haldorsen, Ingfrid S.
Trovik, Jone
Krakstad, Camilla
-
Funding
Funding for this research was provided by:
Norges Forskningsråd (326348)
Helse Vest (F-12542)
Kreftforeningen (223283)
Universitetet i Bergen
- License Information
-
More Information
Article History
Received: 2 July 2024
Revised: 17 September 2024
Accepted: 23 September 2024
First Online: 18 October 2024
Competing interests
: The authors declare no competing interests.
: The study has been approved by the Western Regional Committee for Medical and Health Research Ethics (REK 2015/594) according to Norwegian legislation and regulations. All methods were performed in accordance with Norwegian guidelines and regulations. Samples were provided by Bergen Biobank for gynecological cancer (REK 2014/1907), Women´s Clinic, Haukeland University Hospital, Bergen, Norway. Clinicopathological data and follow-up information are stored in the Bergen Gynecological Cancer Health Registry (approved by the Norwegian Data Inspectorate 2016/7421 and Regional Ethical Committee, REK 7226). All patients gave written and informed consent prior to inclusion.
